Rubinstein Julie sold 11,466 shares of Adaptive Biotechnologies Corp at $28.93 for −$332k on Nov 13, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
President and COO
President and COO
Filed Nov 13, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$331,711.38Shares × reported price
Shares traded
11,466Common Stock
Price per share
$28.93Reported price. Read footnotes for ranges.
% of reported position traded
2.95%This security and ownership context
Holdings after
377,802Direct
Trade date
Nov 13, 2026Sell
Filed
Nov 13, 2026, 7:59 PM ET1-day reporting delay
Accession
0001780664-26-000055Code S · Transaction 401416
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 389,268 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 11, 2026Option exercise11,881$12.14$144,235.34Trade 401410
Nov 12, 2026Option exercise11,881$12.14$144,235.34Trade 401413
Nov 13, 2026Option exercise11,466$12.14$139,197.24Trade 401415
Nov 11, 2026Option exercise11,881$0.00$0Trade 401417
Nov 12, 2026Option exercise11,881$0.00$0Trade 401418
Nov 13, 2026Option exercise11,466$0.00$0Trade 401419
Nov 11, 2026Sell4,983$30.29−$150,935.07Trade 401411
Nov 11, 2026Sell6,898$31.22−$215,355.56Trade 401412
Nov 12, 2026Sell11,881$29.40−$349,301.40Trade 401414
10 transaction rows in this filing. Joint filers share the same rows.

ADPT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ADPT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 21, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −12%1w ago −3.7%1d ago +1.5%
Returns since7d30d90d180d1y

Footnotes in full

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. F2: The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.91 to $30.83, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4. F3: The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.96 to $31.63, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4. F4: The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.74 to $29.73, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4. F5: The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.43 to $29.31, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4. F6: The option is fully vested and exercisable.